Filing excerpt
GAAP diluted EPS of $(0.14) driven primarily by transaction-related charges; Non-GAAP diluted EPS of $2.62, reflecting $284 million of acquired IPR&D, upfront and milestone expense
Source: Autobound Signal API · 76 signals tracked for Biogen · updated
Get Biogen's live signals in Claude or ChatGPT, or by API
What changed at Biogen this week? Use Autobound signals for biogen.com.Third quarter 2026 GAAP diluted EPS fell 104% to $(0.14), while Non-GAAP diluted EPS declined 46% to $2.62, driven by $284 million in acquired IPR&D, upfront and milestone expenses, as well as higher R&D and SG&A costs.
Filing excerpt
GAAP diluted EPS of $(0.14) driven primarily by transaction-related charges; Non-GAAP diluted EPS of $2.62, reflecting $284 million of acquired IPR&D, upfront and milestone expense
What this signalsFilings often name leadership changes, deals and spending plans.
sec-8kmarginPressureGet every 8-K signal for Biogen and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Biogen this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/d135841c-c6c6-4399-8348-d2c8e98bc2b7 returns this record as JSON. POST /v1/companies/enrich returns every signal for biogen.com.
{
"signal_id": "d135841c-c6c6-4399-8348-d2c8e98bc2b7",
"signal_type": "sec-8k",
"signal_subtype": "marginPressure",
"detected_at": "2026-11-03T07:09:36.333+00:00",
"company": {
"name": "Biogen",
"domain": "biogen.com"
},
"data": {
"detail": "Third quarter 2026 GAAP diluted EPS fell 104% to $(0.14), while Non-GAAP diluted EPS declined 46% to $2.62, driven by $284 million in acquired IPR&D, upfront and milestone expenses, as well as higher R&D and SG&A costs. This margin compression and expense increase may create vendor evaluation opportunities for clinical trial efficiency solutions and cost management tools.",
"metrics": {
"pct": -1.04,
"timeframe": "current_quarter",
"pct_context": "decline in GAAP diluted EPS compared to Q3 2025",
"dollar_context": "acquired IPR&D, upfront and milestone expense primarily related to the acquisition of RayThera Inc.",
"dollar_millions": 284
},
"summary": "Biogen reports Q3 GAAP diluted EPS decline to $(0.14) amid higher expenses",
"excerpts": "GAAP diluted EPS of $(0.14) driven primarily by transaction-related charges; Non-GAAP diluted EPS of $2.62, reflecting $284 million of acquired IPR&D, upfront and milestone expense",
"relevance": 0.75,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000094/biib-20261028.htm",
"filing_date": "2026-10-28",
"filing_year": 2026,
"fiscal_year_end": "10/28",
"sales_relevance": "Efficiency tools needed",
"signal_category": "financial"
}
}
curl https://signals.autobound.ai/v1/signals/d135841c-c6c6-4399-8348-d2c8e98bc2b7 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"biogen.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.